ModiQuest Research B.V. is rated 3 out of 5 in the category biotechnology. Read and write reviews about ModiQuest Research B.V.. Founded in 2004 by Dr. Jos Raats, ModiQuest Research is one of the leading custom antibody generation and development providers. ModiQuest Research specializes in the generation of monoclonal antibodies against difficult targets for R&D, diagnostic and therapeutic applications. Using our proprietary ModiVacc™ (hyper-immune stimulatory cell immunization), ModiFuse™ (electrofusion-based hybridoma generation), ModiSelect™ (antigen-specific B-cell selection) and ModiPhage™ (phage display) technologies, we can generate monoclonal antibodies from multiple species against virtually any target. Besides lead antibody generation, we also provide antibody engineering (ModiTune™), such as affinity maturation and humanization, and production (ModiXpress™) in transient and stable mammalian cell systems. All services are offered on a fee-for-service basis. The ModiQuest team consists of highly skilled and experienced scientists and professionals, fully dedicated and focused on the successful execution and completion of client projects. In addition, the team is constantly working on optimizing and expanding our technology platform to ensure a unique and high-quality services and product offering. www.modiquestresearch.com
Company size
11-50 employees
Headquarters
Oss, Brabant